Comparison of Two Chemotherapy Regimens After First-Line Treatment for HER2-Negative Metastatic Gastric Cancer.

Zuhat Urakçı,Senar Ebinç,Sezai Tunç,Ziya Kalkan,Zeynep Oruç,Mehmet Küçüköner,Muhammet Ali Kaplan,Abdurrahman Isikdogan

Cureus（2023）

引用 0|浏览10

暂无评分

摘要

This study determined that FOLFIRI and paclitaxel+carboplatin treatments have similar OS, PFS, and side effect profiles in subsequent line treatment of gastric cancer. The FOLFIRI treatment regimen yielded a higher ORR.

查看译文

关键词

comparison of chemotherapy, subsequent -line treatments, paclitaxel, folfiri, gastric cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要